BNP PARIBAS FINANCIAL MARKETS - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 64 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$32,362,000
+0.7%
10,970
+7.9%
0.00%
Q3 2015$32,128,000
+49.8%
10,167
+180.7%
0.00%
Q2 2015$21,442,000
+156.8%
3,622
+363.8%
0.00%
Q1 2015$8,349,000
-61.1%
781
-72.1%
0.00%
Q3 2014$21,481,000
+754.5%
2,797
+898.9%
0.00%
Q2 2014$2,514,000
+988.3%
280
+483.3%
0.00%
Q1 2014$231,000
-59.5%
48
-78.8%
0.00%
Q4 2013$570,0002260.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q1 2014.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders